Charles J Decedue

This inventor holds 14 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Crititech, Inc., Critltech, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles J Decedue. Retrieved from https://idiyas.com/inventor/charles-j-decedue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 40(Granted Patents)

Company Filing History:

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

Solid Tumor Treatment

Antineoplastic Particles

Immunotherapeutic Agents

Epithelial Cysts

Intracystic Injection

Local Delivery

Systemic Delivery

Particle Processing

Cancer Therapy

Combination Therapy

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12390459 - Methods for solid tumor treatment (2025-08-19),

2. 12329858 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2025-06-17),

3. 12128131 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2024-10-29),

4. 11918691 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2024-03-05),

5. 11737972 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2023-08-29),

6. 11583499 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2023-02-21),

7. 11523983 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2022-12-13),

8. 11458133 - Methods for solid tumor treatment (2022-10-04),

9. 11058639 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2021-07-13),

10. 11033542 - Methods for solid tumor treatment (2021-06-15),

11. 10894045 - Methods for solid tumor treatment (2021-01-19),

12. 10874660 - Methods for solid tumor treatment (2020-12-29),

13. 10391090 - Methods for solid tumor treatment (2019-08-27),

14. 9925512 - Equipment assembly for and method of processing particles (2018-03-27),

Title: The Inventor Profile of Charles J Decedue

Introduction: Charles J Decedue is a renowned inventor based in Lawrence, Kansas, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Charles J Decedue holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Charles J Decedue has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, Charles J Decedue has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Charles J Decedue's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions, inspiring future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.